Runping Liu1, Jason D Kang1, R Balfour Sartor2, Masoumeh Sikaroodi3, Andrew Fagan4, Edith A Gavis4, Huiping Zhou1, Phillip B Hylemon1, Jeremy W Herzog2, Xiaojiaoyang Li1, Robert H Lippman5, Javier Gonzalez-Maeso6, James B Wade7, Siddhartha Ghosh8, Emily Gurley1, Patrick M Gillevet3, Jasmohan S Bajaj4. 1. Division of Microbiology and Immunology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA. 2. National Gnotobiotic Rodent Resource Center, Departments of Medicine, Microbiology, and Immunology, University of North Carolina, Chapel Hill, NC. 3. Center for Microbiome Analysis, George Mason University, Manassas, VA. 4. Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA. 5. Department of Pathology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA. 6. Department of Physiology and Biophysics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA. 7. Department of Psychiatry, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA. 8. Division of Nephrology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA.
Abstract
Cirrhosis and hepatic encephalopathy (HE) is associated with an altered gut-liver-brain axis. Fecal microbial transplant (FMT) after antibiotics improves outcomes in HE, but the impact on brain function is unclear. The aim of this study is to determine the effect of colonization using human donors in germ-free (GF) mice on the gut-liver-brain axis. GF and conventional mice were made cirrhotic using carbon tetrachloride and compared with controls in GF and conventional state. Additional GF mice were colonized with stool from controls (Ctrl-Hum) and patients with cirrhosis (Cirr-Hum). Stools from patients with HE cirrhosis after antibiotics were pooled (pre-FMT). Stools from the same patients 15 days after FMT from a healthy donor were also pooled (post-FMT). Sterile supernatants were created from pre-FMT and post-FMT samples. GF mice were colonized using stools/sterile supernatants. For all mice, frontal cortex, liver, and small/large intestines were collected. Cortical inflammation, synaptic plasticity and gamma-aminobutyric acid (GABA) signaling, and liver inflammation and intestinal 16s ribosomal RNA microbiota sequencing were performed. Conventional cirrhotic mice had higher degrees of neuroinflammation, microglial/glial activation, GABA signaling, and intestinal dysbiosis compared with other groups. Cirr-Hum mice had greater neuroinflammation, microglial/glial activation, and GABA signaling and lower synaptic plasticity compared with Ctrl-Hum mice. This was associated with greater dysbiosis but no change in liver histology. Pre-FMT material colonization was associated with neuroinflammation and microglial activation and dysbiosis, which was reduced significantly with post-FMT samples. Sterile pre-FMT and post-FMT supernatants did not affect brain parameters. Liver inflammation was unaffected. Conclusion: Fecal microbial colonization from patients with cirrhosis results in higher degrees of neuroinflammation and activation of GABAergic and neuronal activation in mice regardless of cirrhosis compared with those from healthy humans. Reduction in neuroinflammation by using samples from post-FMT patients to colonize GF mice shows a direct effect of fecal microbiota independent of active liver inflammation or injury.
Cirrhosis and hepatic encephalopathy (HE) is associated with an altered gut-liver-brain axis. Fecal microbial transplant (FMT) after antibiotics improves outcomes in HE, but the impact on brain function is unclear. The aim of this study is to determine the effect of colonization using human donors in germ-free (GF) mice on the gut-liver-brain axis. GF and conventional mice were made cirrhotic using carbon tetrachloride and compared with controls in GF and conventional state. Additional GF mice were colonized with stool from controls (Ctrl-Hum) and patients with cirrhosis (Cirr-Hum). Stools from patients with HE cirrhosis after antibiotics were pooled (pre-FMT). Stools from the same patients 15 days after FMT from a healthy donor were also pooled (post-FMT). Sterile supernatants were created from pre-FMT and post-FMT samples. GF mice were colonized using stools/sterile supernatants. For all mice, frontal cortex, liver, and small/large intestines were collected. Cortical inflammation, synaptic plasticity and gamma-aminobutyric acid (GABA) signaling, and liver inflammation and intestinal 16s ribosomal RNA microbiota sequencing were performed. Conventional cirrhotic mice had higher degrees of neuroinflammation, microglial/glial activation, GABA signaling, and intestinal dysbiosis compared with other groups. Cirr-Hum mice had greater neuroinflammation, microglial/glial activation, and GABA signaling and lower synaptic plasticity compared with Ctrl-Hum mice. This was associated with greater dysbiosis but no change in liver histology. Pre-FMT material colonization was associated with neuroinflammation and microglial activation and dysbiosis, which was reduced significantly with post-FMT samples. Sterile pre-FMT and post-FMT supernatants did not affect brain parameters. Liver inflammation was unaffected. Conclusion: Fecal microbial colonization from patients with cirrhosis results in higher degrees of neuroinflammation and activation of GABAergic and neuronal activation in mice regardless of cirrhosis compared with those from healthy humans. Reduction in neuroinflammation by using samples from post-FMT patients to colonize GF mice shows a direct effect of fecal microbiota independent of active liver inflammation or injury.
Authors: Jasmohan S Bajaj; Christine M Schubert; Douglas M Heuman; James B Wade; Douglas P Gibson; Allyne Topaz; Kia Saeian; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Melanie B White; Arun J Sanyal Journal: Gastroenterology Date: 2010-02-20 Impact factor: 22.682
Authors: Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong Journal: Hepatology Date: 2014-07-08 Impact factor: 17.425
Authors: Stephan J Ott; Georg H Waetzig; Ateequr Rehman; Jacqueline Moltzau-Anderson; Richa Bharti; Juris A Grasis; Liam Cassidy; Andreas Tholey; Helmut Fickenscher; Dirk Seegert; Philip Rosenstiel; Stefan Schreiber Journal: Gastroenterology Date: 2016-11-17 Impact factor: 22.682
Authors: Dae Joong Kang; Naga S Betrapally; Siddhartha A Ghosh; R Balfour Sartor; Phillip B Hylemon; Patrick M Gillevet; Arun J Sanyal; Douglas M Heuman; Daniel Carl; Huiping Zhou; Runping Liu; Xiang Wang; Jing Yang; Chunhua Jiao; Jeremy Herzog; H Robert Lippman; Masoumeh Sikaroodi; Robert R Brown; Jasmohan S Bajaj Journal: Hepatology Date: 2016-07-29 Impact factor: 17.425
Authors: Nan Qin; Fengling Yang; Ang Li; Edi Prifti; Yanfei Chen; Li Shao; Jing Guo; Emmanuelle Le Chatelier; Jian Yao; Lingjiao Wu; Jiawei Zhou; Shujun Ni; Lin Liu; Nicolas Pons; Jean Michel Batto; Sean P Kennedy; Pierre Leonard; Chunhui Yuan; Wenchao Ding; Yuanting Chen; Xinjun Hu; Beiwen Zheng; Guirong Qian; Wei Xu; S Dusko Ehrlich; Shusen Zheng; Lanjuan Li Journal: Nature Date: 2014-07-23 Impact factor: 49.962
Authors: Jasmohan S Bajaj; Masoumeh Sikaroodi; Andrew Fagan; Douglas Heuman; HoChong Gilles; Edith A Gavis; Michael Fuchs; Javier Gonzalez-Maeso; Shahzor Nizam; Patrick M Gillevet; James B Wade Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-08-28 Impact factor: 4.052
Authors: Jennifer T Wolstenholme; Justin M Saunders; Maren Smith; Jason D Kang; Phillip B Hylemon; Javier González-Maeso; Andrew Fagan; Derrick Zhao; Masoumeh Sikaroodi; Jeremy Herzog; Amirhossein Shamsaddini; Marcela Peña-Rodríguez; Lianyong Su; Yun-Ling Tai; Jing Zheng; Po-Cheng Cheng; R Balfour Sartor; Patrick M Gillevet; Huiping Zhou; Jasmohan S Bajaj Journal: Nat Commun Date: 2022-10-19 Impact factor: 17.694
Authors: Jasmohan S Bajaj; Nita Salzman; Chathur Acharya; Hajime Takei; Genta Kakiyama; Andrew Fagan; Melanie B White; Edith A Gavis; Mary L Holtz; Michael Hayward; Hiroshi Nittono; Phillip B Hylemon; I Jane Cox; Roger Williams; Simon D Taylor-Robinson; Richard K Sterling; Scott C Matherly; Michael Fuchs; Hannah Lee; Puneet Puri; R Todd Stravitz; Arun J Sanyal; Lola Ajayi; Adrien Le Guennec; R Andrew Atkinson; Mohammad S Siddiqui; Velimir Luketic; William M Pandak; Masoumeh Sikaroodi; Patrick M Gillevet Journal: JCI Insight Date: 2019-12-19
Authors: Yuan Zhang; Jason D Kang; Derrick Zhao; Siddartha S Ghosh; Yanyan Wang; Yunling Tai; Javier Gonzalez-Maeso; Masoumeh Sikaroodi; Patrick M Gillevet; H Robert Lippman; Phillip B Hylemon; Huiping Zhou; Jasmohan S Bajaj Journal: Front Physiol Date: 2021-06-25 Impact factor: 4.566